|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/24 | |||
| A61P 37/00 | |||
| A61P 9/00 | |||
| A61P 9/12 |
| (11) | Patento numeris | 2464370 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10808864.2 |
| Europos patento paraiškos padavimo data | 2010-08-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/045605 |
| Data | 2010-08-16 |
| (87) | Numeris | WO 2011/020091 |
| Data | 2011-02-17 |
| (30) | Numeris | Data | Šalis |
| 234151 P | 2009-08-14 | US |
| (72) |
SADEGHI, Homayoun, US
TURNER, Andrew, US
DAGHER, Suzanne, US
|
| (73) |
Phasebio Pharmaceuticals, Inc.,
One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355,
US
|
| (54) | MODIFIED VASOACTIVE INTESTINAL PEPTIDES |
| MODIFIED VASOACTIVE INTESTINAL PEPTIDES |